Scaling Smart: Transitioning from R&D to Commercial Operations for Broader Patient Access
- Building operational efficiency to reduce costs while maintaining speed, reliability, and quality in therapy delivery
- Prioritizing commercial capabilities alongside scientific expertise to support larger patient populations and sustainable growth
- Re-evaluating processes for scalability, reliability, and strong unit economics to ensure cost-effective operations without compromising therapy integrity